RSS

Topas Therapeutics

Hamburg-based private platform company, Topas Therapeutics, has signed a multi-year agreement with Boehringer Ingelheim to collaborate in the field of antigen-specific tolerance induction. more

News

Topas Therapeutics, a German-based platform company, will serve as the exclusive translational partner for the recently extended Collaborative Research Center (CRC) 841, ‘Liver inflammation: infection, immune regulation and consequences’. more

News